BBVA USA Bancshares’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | $606K | Sell |
7,245
-186
| -3% | -$15.6K | 0.03% | 371 |
|
|
2020
Q4 | $678K | Buy |
7,431
+1,794
| +32% | +$164K | 0.03% | 346 |
|
|
2020
Q3 | $449K | Sell |
5,637
-4
| -0.1% | -$319 | 0.03% | 376 |
|
|
2020
Q2 | $389K | Sell |
5,641
-212
| -4% | -$14.6K | 0.02% | 403 |
|
|
2020
Q1 | $368K | Sell |
5,853
-792
| -12% | -$49.8K | 0.03% | 373 |
|
|
2019
Q4 | $517K | Buy |
+6,645
| New | +$517K | 0.03% | 366 |
|
|
2019
Q3 | – | Sell |
-6,843
| Closed | -$422K | – | 425 |
|
|
2019
Q2 | $422K | Buy |
6,843
+1,293
| +23% | +$79.7K | 0.03% | 394 |
|
|
2019
Q1 | $354K | Buy |
5,550
+777
| +16% | +$49.6K | 0.02% | 418 |
|
|
2018
Q4 | $244K | Sell |
4,773
-756
| -14% | -$38.6K | 0.02% | 448 |
|
|
2018
Q3 | $321K | Buy |
+5,529
| New | +$321K | 0.02% | 448 |
|
|
2017
Q4 | – | Sell |
-7,959
| Closed | -$290K | – | 536 |
|
|
2017
Q3 | $290K | Sell |
7,959
-621
| -7% | -$22.6K | 0.02% | 458 |
|
|
2017
Q2 | $338K | Buy |
8,580
+276
| +3% | +$10.9K | 0.02% | 432 |
|
|
2017
Q1 | $260K | Buy |
8,304
+1,893
| +30% | +$59.3K | 0.02% | 488 |
|
|
2016
Q4 | $200K | Buy |
6,411
+606
| +10% | +$18.9K | 0.01% | 535 |
|
|
2016
Q3 | $233K | Buy |
+5,805
| New | +$233K | 0.02% | 512 |
|